References
- Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention. Stroke 2006;37:577–617
- Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665–73
- O’Donnell M, Eikelboom J. ESPRIT trial [letter]. Lancet 2006;368:447
- Filippi A. ESPRIT trial [letter]. Lancet 2006;368:447–8
- Flaherty M, Kissela B, Broderick J. ESPRIT trial [letter]. Lancet 2006;368:448
- von Maxen A, Wille H, Schönhöfer P. ESPRIT trial [letter]. Lancet 2006;368:448–9
- Halkes PH, van Gijn J, Kappelle LJ, et al. ESPRIT trial [author reply]. Lancet 2006;368:449
- Hansson L, Hedner T, Dahlof B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective randomized open blinded end point. Blood Press 1992;1:113–9
- Norrving B. Dipyridamole with aspirin for secondary stroke prevention. Lancet 2006;367:1638–9
- De Schryver EL. ESPRIT: protocol change. Cerebrovasc Dis 2001;11:286
- Medical Research Council. A framework for the development and evaluation of RCTs for complex interventions to improve health. UK, April 2000. Internet: http://www.gprf.mrc.ac.uk/ [accessed 6 December 2006]
- Hart RG, Harrison MJ. Aspirin wars: the optimal dose of aspirin to prevent stroke. Stroke 1996;27:585–7
- The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. New Engl J Med 1991;325:1261–6
- Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044–54
- Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71–86
- Diener H, Cunha L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1–13